We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 1.31 | 0.87% | 151.22 | 152.00 | 149.705 | 150.04 | 5,627,882 | 22:05:53 |
From May 2022 to May 2024
By Dean Seal
Shares of Sonnet BioTherapeutics Holdings Inc. were up by over a third to $2.62 in early trading, building on gains from the day before when the company announced a collaboration with Johnson & Johnson's Janssen Biotech Inc.
On Monday, the company said that three of its product candidates will be evaluated in combination with Janssen's proprietary cell therapy assets.
Sonnet's shares jumped 66% to close at $1.93 on Monday. They opened at $1.98 on Tuesday and surged to a high of $3 before edging back to a gain of 35% in morning trading.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
November 01, 2022 11:30 ET (15:30 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
